|
⚲
|
| Keyboard |
| Passage Bio Inc | |
|---|---|
| Ticker | PASG |
| CIK # | 0001787297 |
| CUSIP | 702712100 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | Two Commerce Square 2001 Market Street, 28th Floor, Philadelphia, PA 19103 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Passage Bio Inc | 2019-09-06 | 110.0 M | Exemption: 506(b), 3(c), 3(c)(1) · Remaining: $26 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001787297] | 10-K | |
| [0001787297] | 10-Q | |
| [0001787297] | 3 | |
| [0001787297] | 4 | |
| [0001787297] | 8-K | |
| [0001787297] | D | |
| [0001787297] | SC 13D | |
| [0001787297] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Borthwick Kathleen
Employee Stock Option (right to buy) · derivative
|
2026-03-16 | Grant | 15,610 | $0.00 | |
|
Chou William
Employee Stock Option (right to buy) · derivative
|
2026-03-16 | Grant | 58,000 | $0.00 | |
|
Chou William
Common Stock
|
2026-01-08 | Sell | 4,076 | $18.44 | 75,161 |
|
Borthwick Kathleen
Common Stock
|
2026-01-08 | Sell | 2,062 | $18.44 | 38,023 |
|
Chou William
Restricted Stock Unit · derivative
|
2026-01-08 | Option exercise | 10,000 | $0.00 | |
|
Chou William
Common Stock
|
2026-01-08 | Option exercise | 10,000 | ||
|
Borthwick Kathleen
Restricted Stock Unit · derivative
|
2026-01-08 | Option exercise | 5,000 | $0.00 | |
|
Borthwick Kathleen
Common Stock
|
2026-01-08 | Option exercise | 5,000 | ||
|
Common Stock
|
2025-09-15 | Buy | 11,900 | $6.99 | 83,181 |
|
Common Stock
|
2025-09-12 | Buy | 19,783 | $6.99 | 138,283 |
|
Common stock, $0.0001 par value per share (Common Stock)
|
2025-09-11 | Buy | 325 | $6.96 | 2,262 |
|
Nichols Weston +1
Common Stock
|
2025-07-24 | Buy | 66,423 | $5.71 | 379,275 |
|
Nichols Weston +1
Common Stock
|
2025-07-23 | Buy | 49,302 | $5.74 | 282,993 |
|
Nichols Weston +1
"Common stock, $0.0001 par value per share (""Common Stock"")"
|
2025-07-22 | Buy | 13,123 | $5.44 | 71,389 |
|
OrbiMed Advisors LLC +1
Common Stock
|
2025-06-26 | Sell | 213,257 | $0.33 | 70,375 |
|
OrbiMed Advisors LLC +1
Common Stock
|
2025-06-25 | Sell | 138,800 | $0.33 | 45,804 |
|
OrbiMed Advisors LLC +1
Common Stock
|
2025-06-24 | Sell | 231,600 | $0.35 | 81,060 |
|
Gowen Maxine
Director Stock Option (right to buy) · derivative
|
2025-05-28 | Grant | 201,857 | $0.00 | |
|
Kapadia Sandip
Director Stock Option (right to buy) · derivative
|
2025-05-28 | Grant | 201,857 | $0.00 | |
|
Countouriotis Athena
Director Stock Option (right to buy) · derivative
|
2025-05-28 | Grant | 201,857 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2025-09-30 | 2 | 87,427 |
| 2025-06-30 | 41 | 35,095,792 |
| 2025-03-31 | 45 | 36,370,242 |
| 2024-12-31 | 48 | 37,640,901 |
| 2024-09-30 | 46 | 38,675,230 |
| 2024-06-30 | 46 | 40,286,539 |
| 2024-03-31 | 52 | 40,351,913 |
| 2023-12-31 | 53 | 32,775,517 |
| 2023-09-30 | 52 | 32,396,126 |
| 2023-06-30 | 57 | 33,315,153 |
| 2023-03-31 | 60 | 35,554,684 |
| 2022-12-31 | 69 | 37,341,517 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares | Prev | Page 1 | Next |